GLP-1 Check — India's GLP-1 Information & Self-Assessment Tool
All Semaglutide Brands India
Generic SemaglutideType 2 Diabetes + ObesityLowest price in India
Eris Lifesciences / Natco Pharma logo

SUNDAE/ Semanat / SemafullGeneric semaglutide for type 2 diabetes + obesity in India 2026

by Eris Lifesciences / Natco Pharma · ₹220 per shot · DCGI approved February 2026 (CDSCO)

Active ingredient
Semaglutide (GLP-1 receptor agonist)
Indication
Type 2 Diabetes + Obesity
Manufacturer
Eris Lifesciences Ltd (with Natco Pharma)
DCGI status
Approved February 2026 (CDSCO)
Price (MRP)
₹220 per shot
Globally lowest entry price for any semaglutide product. Vial format suited to clinic/hospital administration; pen device launched April 2026.
Format
Multi-dose vial + Pen
Prescription
Schedule H — required

How SUNDAE compares

SUNDAE has the lowest entry price of any semaglutide product in India — and globally — at ₹220 per shot. The multi-dose vial format is best suited for hospital and clinic settings where nurses administer doses; a pen device launched April 2026 for self-administration. Semanat and Semafull are sister brand names by Eris/Natco's commercial partners.

About Eris Lifesciences / Natco Pharma

Natco Pharma developed the formulation; Eris Lifesciences leads the commercialisation in India through its endocrinologist and diabetologist sales force. The Eris–Natco partnership is one of the most aggressively-priced Indian generic plays, driving the broader market price floor.

Who is SUNDAE for?

SUNDAE is approved in India for both type 2 diabetes and chronic weight management in adults with obesity. Indian guideline eligibility typically requires BMI ≥27.5 (obesity indication) or HbA1c above target on first-line therapy (T2D indication). Patients with BMI ≥25 + comorbidities (PCOS, NAFLD, hypertension, sleep apnea) may also qualify under specialist judgment.

Not sure if you qualify? Take the 5-minute Indian-guideline eligibility check →

SUNDAE for specific conditions

SUNDAE for PCOS →SUNDAE for fatty liver (NAFLD/MASLD) →SUNDAE for hypertension + obesity →SUNDAE for sleep apnea + obesity →

SUNDAE cost in India

MRP for SUNDAE: ₹220 per shot. Actual pharmacy pricing varies by city, pharmacy, and channel. Online prescription pharmacies typically offer modest discounts off MRP with cold-chain delivery; hospital pharmacy pricing is usually at MRP.

Compare with all India brands: GLP-1 therapy cost in India 2026 →

Compared to other GLP-1 brands in India

SUNDAE is an Indian generic semaglutide. Same active molecule as Ozempic and Wegovy (Novo Nordisk innovator brands), with clinical efficacy that follows the molecule rather than the brand. Other Indian generics include Sundae, Noveltreat, Obeda, Semaglyn, Sembolic, and Samakind — all at similar price points.

All GLP-1 comparisons →All Indian semaglutide brands →Clinical evidence library →GLP-1 blog (India) →

SUNDAE — frequently asked questions

Is SUNDAE available in India? Is it DCGI-approved?+
Yes — SUNDAE is DCGI-approved and currently available across India. The drug received DCGI approval in February 2026 (CDSCO) for both type 2 diabetes and obesity, manufactured by Eris Lifesciences Ltd (with Natco Pharma). It is distributed through licensed retail and online prescription pharmacies and hospital pharmacies across Indian metros and most tier-2 cities. SUNDAE is a Schedule H drug — a doctor's prescription is required. Take the GLP-1 Check 5-minute Indian-guideline assessment to see if you qualify.
What does SUNDAE cost in India in 2026?+
SUNDAE is priced at ₹220 per shot (Globally lowest entry price for any semaglutide product. Vial format suited to clinic/hospital administration; pen device launched April 2026.). Actual pharmacy pricing may vary by city and channel. For brand-by-brand price comparisons across all India brands, see our cost guide. Take the GLP-1 Check 5-minute Indian-guideline assessment to see if you qualify.
Do I need a prescription to buy SUNDAE?+
Yes — SUNDAE is a Schedule H drug in India and can only be dispensed against a valid prescription from a registered medical practitioner. Any legitimate online prescription pharmacy will require you to upload your prescription before order fulfillment.
Who is SUNDAE for?+
SUNDAE is approved for both type 2 diabetes and obesity in India. Indian guideline eligibility typically requires BMI ≥27.5 (obesity indication) or HbA1c above target on first-line therapy (T2D indication), often with comorbidities at BMI ≥25. Take the GLP-1 Check 5-minute Indian-guideline assessment to see if you qualify.
How does SUNDAE compare to Ozempic and Wegovy?+
SUNDAE contains the same active molecule (semaglutide) as Ozempic and Wegovy. Clinical efficacy is comparable; the difference is brand, manufacturer support, pen design, and price. SUNDAE (₹220 per shot) is meaningfully cheaper than Ozempic (₹5,660+/month) or Wegovy (up to ₹16,400/month) — useful for cost-sensitive patients on long-term therapy.
Where can I buy SUNDAE in India?+
SUNDAE is a Schedule H drug — available through licensed retail and online prescription pharmacies and hospital pharmacies across India with a doctor's prescription. Always buy from a licensed pharmacy to avoid counterfeit products; never use sources that dispense without verifying a prescription. Take the GLP-1 Check 5-minute Indian-guideline assessment to see if you qualify.

Source

Business Today — SUNDAE launch coverage

GLP-1 Check is informational, not a medical diagnosis. Semaglutide is a Schedule H drug in India and requires a prescription from a registered medical practitioner. Always consult a qualified physician before starting any treatment.

Are you eligible for SUNDAE?

Take the free 5-minute triage to check your GLP-1 readiness against Indian clinical guidelines.

Check My Eligibility →

Looking at other brands?

See full price comparison across all 25+ DCGI-approved brands →